SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004233
Filing Date
2019-05-07
Accepted
2019-05-07 15:55:51
Documents
60
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20190331x10q.htm 10-Q 1145112
2 EX-10.1 imgn-20190331ex101f28d63.htm EX-10.1 75271
3 EX-31.1 imgn-20190331ex3117902d7.htm EX-31.1 11571
4 EX-32 imgn-20190331xex32.htm EX-32 7824
  Complete submission text file 0001558370-19-004233.txt   5074888

Data Files

Seq Description Document Type Size
5 EX-101.INS imgn-20190331.xml EX-101.INS 851282
6 EX-101.SCH imgn-20190331.xsd EX-101.SCH 49740
7 EX-101.CAL imgn-20190331_cal.xml EX-101.CAL 40098
8 EX-101.DEF imgn-20190331_def.xml EX-101.DEF 189755
9 EX-101.LAB imgn-20190331_lab.xml EX-101.LAB 467771
10 EX-101.PRE imgn-20190331_pre.xml EX-101.PRE 340147
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 19802939
SIC: 2834 Pharmaceutical Preparations